Download PDF
Thromb Haemost 1986; 56(02): 115-119
DOI: 10.1055/s-0038-1661622
Original Article
Schattauer GmbH Stuttgart

Specificity of the Thrombin-Induced Release of Tissue Plasminogen Activator from Cultured Human Endothelial Cells

Eugene G Levin
1   The Department of Basic and Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California
,
David M Stern
2   The Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma
,
Peter P Nawroth
2   The Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma
,
Richard A Marlar
3   The Blood Center of South Eastern Wisconsin, Milwaukee, Wisconsin
,
Daryl S Fair
4   The Department Immunology, Scripps Clinic and Research Foundation, La Jolla, California
,
John W Fenton II
5   The Department of Health, Albany, New York, USA
,
Laurence A Harker
1   The Department of Basic and Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California
› Author Affiliations
Further Information

Publication History

Received 18 March 1986

Accepted 12 June 1986

Publication Date:
20 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The addition of thrombin (9 nM) to primary cultures of human endothelial cells induces a 6- to 7-fold increase in the rate of release of tissue plasminogen activator (tPA). Several other serine proteases which specifically interact with endothelial cells were also analyzed for their effect on tPA release. Gamma-thrombin, an autocatalytic product of α-thrombin, promoted tPA release but was less effective than α-thrombin. A maximum increase of 5.5-fold was observed, although a concentration of γ-thrombin 20 times greater than α-thrombin was required. The response to Factor Xa was similar to α-thrombin, although the stimulation was significantly reduced by the addition of hirudin or DAPA suggesting that prothrombin activation was occurring. The simultaneous addition of prothrombin with Factor Xa resulted in enhanced tPA release equal to that observed with an equimolar concentration of active α-thrombin. Thus, under these conditions, Factor Xa-cell surface mediated activation of prothrombin can lead to a secondary effect resulting from cell-thrombin interaction. Activated protein C, which has been implicated as a profibrinolytic agent, was also tested. No change in tPA release occurred after the addition of up to 325 nM activated protein C in the presence or absence of proteins. Factor IXa and plasmin were also ineffective. The effect of thrombin on the endothelial cell derived plasminogen activator specific inhibitor was also studied. Thrombin produced a small but variable release of the inhibitor with an increase of less than twice that of non-thrombin treated controls.

Key words

Thrombin - Tissue plasminogen activator - Endothelial cells - Plasminogen activator specific inhibitor
 

  • References

  • 1 Levin EG, Marzec U, Anderson J, Harker LA. Thrombin stimulates tissue plasminogen activator release from human endothelial cells. J Clin Invest 1984; 74: 1988-1995
    CrossrefPubMedSearch in Google Scholar
  • 2 Awbrey BJ, Hoak JC, Owen WG. Binding of human thrombin to cultured human endothelial cells. J Biol Chem 1979; 254: 4092-4095
    PubMedSearch in Google Scholar
  • 3 Issacs J, Savion N, Gospodarowicz D, Shuman MA. Effect of cell density on thrombin binding to a specific site on bovine vascular endothelial cells. J Cell Biology 1981; 90: 670-674
    CrossrefPubMedSearch in Google Scholar
  • 4 Lollar P, Hoak JC, Owen WG. Binding of thrombin to cultured endothelial cells. J Biol Chem 1980; 255: 10279-10283
    PubMedSearch in Google Scholar
  • 5 Heimark RL, Schwartz S. Binding of coagulation Factors IX and X to the endothelial cell surface. Biochem Biophys Res Commun 1983; 111: 723-731
    CrossrefPubMedSearch in Google Scholar
  • 6 Stern DM, Nawroth PP, Kisiel W, Handley D, Drillings M, Bartos J. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin. J Clin Invest 1984; 74: 1910-1921
    CrossrefPubMedSearch in Google Scholar
  • 7 Rodgers GM, Shuman MA. Characterization of the interaction between Factor Xa and bovine aortic endothelial cells. Biochim Biophys Acta 1985; 844: 320-329
    CrossrefPubMedSearch in Google Scholar
  • 8 Stern DM, Drillings M, Nossel HL, Hurlet-Jensen A, LaGamma K, Owen J. Binding of Factors IX and IXa to cultured vascular endothelial cells. Proc Natl Acad Sci USA 1983; 80: 4119-4123
    CrossrefPubMedSearch in Google Scholar
  • 9 Stern D, Nawroth P, Kisiel W, Drillings M, Bartos J, Nossel H. A pathway of coagulation from Factor IXa to thrombin formation on the surface of endothelial cells. Blood 1983; 62: 310 A (Abstr)
    PubMedSearch in Google Scholar
  • 10 Bauer PI, Machovich R, Bũki KG, Csonka E, Koch SA, Horvath I. Interaction of plasmin with endothelial cells. Biochem J 1984; 218: 119-124
    CrossrefPubMedSearch in Google Scholar
  • 11 Savion N, Naveh-Floman N. Correlation between trypsin binding to a specific receptor and prostacyclin production in cultured vascular endothelial cells. J Cell Physiol 1985; 122: 142-148
    CrossrefPubMedSearch in Google Scholar
  • 12 Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A23187. J Clin Invest 1978; 62: 923-930
    CrossrefPubMedSearch in Google Scholar
  • 13 Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases anti-activator activity. Proc Natl Acad Sci USA 1985; 82: 1121-1125
    CrossrefPubMedSearch in Google Scholar
  • 14 van Hinsbergh V WM, Bertina RM, van Wijngaards A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator inhibitor activity in endothelial cell conditioned medium. Blood 1985; 65: 444-451
    PubMedSearch in Google Scholar
  • 15 Sprengers ED, Verheijen JH, van Hindsbergh V WM, Emeis JJ. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochim Biophys Acta 1984; 801: 163-170
    CrossrefPubMedSearch in Google Scholar
  • 16 Hekman C, Loskutoff DJ. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturation. J Biol Chem 1985; 260: 11581-11586
    PubMedSearch in Google Scholar
  • 17 Levin EG. Latent tissue plasminogen activator produced by human endothelial cell in culture: Evidence for an enzyme inhibitor complex. Proc Natl Acad Sci USA 1983; 80: 6804-6808
    CrossrefPubMedSearch in Google Scholar
  • 18 Philips M, Juul A-G, Thorsen S. Human endothelial cells produce a plasminogen activator-inhibitor complex. Biochim Biophys Acta 1984; 802: 99-110
    CrossrefPubMedSearch in Google Scholar
  • 19 Collucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-824
    CrossrefPubMedSearch in Google Scholar
  • 20 Sprengers ED, Princen H MG, Koostra T, van Hindsbergh V WM. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2. J Lab Clin Med 1985; 105: 751-758
    PubMedSearch in Google Scholar
  • 21 Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB. Thrombin-mediated release of Factor VIII antigen from human umbilical vein endothelial cells in culture. Blood 1982; 60: 531-534
    PubMedSearch in Google Scholar
  • 22 Unkeless JC, Tobia A, Ossowski L, Quigley JP, Rifkin DB, Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. J Exp Med 1973; 137: 85-111
    CrossrefPubMedSearch in Google Scholar
  • 23 Levin EG. Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells. Blood 1986; 67: 1309-1313
    PubMedSearch in Google Scholar
  • 24 Fair DS. Quantitation of Factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
    PubMedSearch in Google Scholar
  • 25 Schwartz BS, Levy GA, Curtiss LK, Fair DS, Edgington TS. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. I. Two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 1981; 67: 1650-1658
    PubMedSearch in Google Scholar
  • 26 Fenton II JW, Fasco MJ, Stackrow AB, Aronson DL, Young AM, Finlayson JS. Human thrombins. Production, evaluation, and properties of α-thrombin. J - Biol Chem 1977; 252: 3587-3598
    PubMedSearch in Google Scholar
  • 27 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1064-1072
    PubMedSearch in Google Scholar
  • 28 Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-846
    CrossrefPubMedSearch in Google Scholar
  • 29 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
    CrossrefPubMedSearch in Google Scholar
  • 30 Suzuki K, Nishioka J, Hashimoto S. Regulation of activated protein C by thrombin modified protein S. J Biochem 1983; 94: 699-705
    CrossrefPubMedSearch in Google Scholar
  • 31 Walker FJ. Regulation of activated protein C by protein S, the role of phospholipid in Factor Va inactivation. J Biol Chem 1981; 256: 11128-11131
    PubMedSearch in Google Scholar
  • 32 Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985; 260: 2007-2011
    PubMedSearch in Google Scholar
  • 33 Tam SW, Fenton II JW, Detwiler TC. Platelet thrombin receptors: binding of thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem 1980; 255: 6626-6632
    PubMedSearch in Google Scholar
  • 34 Landis BH, Zambinski MP, Lafleur GJ M, Bing DH, Fenton II JW. Human α-and γ-thrombin differential inhibition with hirudin. Fed Proc 1978; 37: 1445 (Abstr)
    PubMedSearch in Google Scholar
  • 35 Berliner LJ. Structure-function relationships in human α- and γ-thrombins. Molec Cell Biochem 1984; 61: 159-172
    PubMedSearch in Google Scholar
  • 36 Fenton II JW, Landis BH, Walz DA, Finlayson JS. Human thrombins. In: Chemistry and Biology of Thrombin Lundblad RL, Fenton II JW, Mann KG. (eds.) Ann Arbor Science Publishers; Ann Arbor, Michigan: 1977. pp. 43-70
  • 37 Fenton II JW, Landis BH, Walz DA, Bing DH, Feinman RD, Zabinski MP, Sonder SA, Berliner LJ, Finlayson JS. Human thrombin: preparative evaluation, structural properties and enzymic specificity. In: The Chemistry and Physiology of Human Plasma Proteins Bing DH. (ed.) Pergamon Press; New York: 1979: 151-183
  • 38 Villanueva GB. Conformational differences between high clotting human α-thrombin and non-clotting γ-thrombin. Biochemistry 1981; 20: 6519-6525
    CrossrefPubMedSearch in Google Scholar
  • 39 Rodgers GM, Shuman MA. Prothrombin is activated on vascular endothelial cells by Factor Xa and calcium. Proc Natl Acad Sci USA 1983; 80: 7001-7005
    CrossrefPubMedSearch in Google Scholar
  • 40 Fair DS, Marlar RA, Levin EG. Human endothelial cells synthesize protein S. Blood 1986; 67: 1168-1171
    PubMedSearch in Google Scholar
  • 41 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
    CrossrefPubMedSearch in Google Scholar
  • 42 Gelherter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986; 77: 165-169
    CrossrefPubMedSearch in Google Scholar